Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for the treatment of cancer

Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for the treatment of cancer

US Patent 12227577 · Granted Feb 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted binding agents against B7-H12022
Combination of a protein kinase inhibitor and an additional chemotherapeutic age2022
Diagnostic anti-PD-L1 antibody and use thereof2020
Targeted binding agents against B7-H12019
Cyclic amides as MetAP-2 inhibitors2018
Pyrrolidinone derivatives as MetAP-2 inhibitors2018
Substituted imidazoquinolines2018
Imidazo[4,5-C]quinolines as DNA-PK inhibitors2017
Targeted binding agents against B7-H12016
Substituted imidazoquinolines2016
Fused bicyclic imidazoles2016
7-azaindole-2,7-naphthyridine derivative for the treatment of tumours2016